Frank Irvin, II v. United States

335 F. App'x 821
CourtCourt of Appeals for the Eleventh Circuit
DecidedJune 4, 2009
Docket08-15489
StatusUnpublished
Cited by4 cases

This text of 335 F. App'x 821 (Frank Irvin, II v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Frank Irvin, II v. United States, 335 F. App'x 821 (11th Cir. 2009).

Opinion

PER CURIAM:

Plaintiff-Appellant Frank Irvin, II appeals from the district court’s dismissal of his complaint challenging the decision by the Veterans Administration Medical Center (the “VAMC”) in Decatur, Georgia to limit its reimbursement for Irvin’s treatment for back pain and seeking damages. On appeal, Irvin’s primary argument is that the district court erred in dismissing his complaint on collateral estoppel grounds because this lawsuit raises a different issue than the one he raised in an *822 earlier lawsuit. After careful review, we affirm.

We review de novo the district court’s legal conclusions, including the applicability of the collateral estoppel doctrine. See United States v. Weiss, 467 F.3d 1300, 1308 (11th Cir.2006). “A district court’s factual determinations underlying its legal conclusion are upheld unless clearly erroneous.” Id. (quotations omitted).

The relevant facts and procedural history are as follows. Plaintiff Irvin is a veteran who receives health benefits from the Department of Veteran Affairs (“VA”), and who has suffered lower back pain caused by lumbar stenosis. He previously was a patient at the North Georgia Pain Clinic (“NGPC”), and while there, his physician treated his back pain with an implanted drug infusion system (also referred to as a morphine pump). Thereafter, Irvin transferred his care from the NGPC to the Atlanta VAMC.

In September of 2003, the VAMC determined that the implanted drug infusion system was medically unnecessary for Irvin’s stenosis, and that his back pain could be addressed using oral medications and a Fenatyl patch. As a result, the VAMC decided that it would reimburse Irvin’s physician for his treatment with the implanted drug infusion system only to the extent needed to wean Irvin off of it. On December 3, 2003, Irvin filed a federal court complaint challenging the VAMC’s reimbursement decision (the “2003 Complaint”). The complaint challenged the VAMC’s decision to limit its reimbursement of Irvin’s treatment with a morphine pump to the taper and removal of the pump, and sought injunctive relief. The government moved to dismiss for lack of subject matter jurisdiction the complaint under the Veterans’ Judicial Review Act (the “VJRA”), which provides:

The Secretary shall decide all questions of law and fact necessary to a decision by the Secretary under a law that affects the provision of benefits by the' Secretary to veterans or the dependents or survivors of veterans.... [T]he decision of the Secretary as to any such question shall be final and conclusive and may not be reviewed by any other official or by any court, whether by an action in the nature of mandamus or otherwise.

38 U.S.C. § 511(a). On January 14, 2004, the district court dismissed the complaint for lack of jurisdiction on grounds that the VJRA barred judicial review of a benefits decision by the VA.

In October of 2004, the VAMC reversed its decision and authorized payment to Irvin’s non-VAMC physician for the morphine pump after the attempts to wean Irvin off of the pump failed. Irvin does not contend that the VAMC ever issued any subsequent denial decisions with regard to the morphine pump after October of 2004.

Nevertheless, in October of 2007, Irvin filed a new complaint (the “2007 Complaint”), challenging the VAMC’s decision to taper and remove his morphine pump, and seeking money damages for his “extreme pain and suffering.” On the government’s motion, the district court dismissed the 2007 Complaint on collateral estoppel grounds — concluding that the issue of the district court’s subject matter jurisdiction to review the VAMC’s reimbursement decision regarding Irvin’s implanted drug infusion system had already been decided, and that Irvin was precluded from relit-igating the same issue again. Irvin now appeals that order.

Collateral estoppel refers to the concept of “issue preclusion,” whereby the re-litigation of an issue that has been previously litigated and decided is precluded. See *823 Christo v. Padgett, 223 F.3d 1324, 1339 (11th Cir.2000). To apply collateral estop-pel, the court must find that the following four prerequisites have been satisfied:

(1) the issue at stake is identical to the one involved in the prior proceeding;
(2) the issue was actually litigated in the prior proceeding;
(3) the determination of the issue in the prior litigation must have been “a critical and necessary part” of the judgment in the first action; and
(4) the party against whom collateral estoppel is asserted must have had a full and fair opportunity to litigate the issue in the prior proceeding.

Id.

On the record here, we disagree with Irvin’s claim that the district court erred in dismissing the 2007 Complaint on collateral estoppel grounds. As for the first prong of the test, the issued involved in both lawsuits is identical. In the 2003 Complaint, Irvin sought to enjoin the VAMC’s order “to reduce my pain management system by 10% every two weeks and remov[e] ... the implanted Meditronic Drug Infusion System.” 2003 Compl. ¶ 2. In the 2007 Complaint, Irvin sought monetary compensation for the pain and suffering caused by the VAMC’s order to “taper and remov[e] ... the Plaintiffs Implanted Drug Infusion System” and substitute with oral medications. 2007 Compl. at 2. Both complaints thus challenge the VAMC’s 2003 order to remove Irvin’s morphine pump — an order that clearly constitutes a “decision by the Secretary ... that affects the provision of benefits by the Secretary to veterans.” 38 U.S.C. § 511(a). As a “decision ... affectfing]” the provision of benefits, the challenged order was subject to Section 511(a) of the VJRA, and as a result, the district court— in both cases — was required to determine whether Section 511(a) prohibited judicial review of the VAMC’s order. Because the issue in both the 2003 and 2007 cases is whether the district court had subject matter jurisdiction over Irvin’s challenge to the VAMC’s 2003 order, the issue is an identical one.

Irvin claims that the issues are different because he was challenging the VAMC’s order in the 2003 Complaint, while he was suing for torts resulting from the VAMC’s order in the 2007. We are unpersuaded. As an initial matter, Irvin does not delineate any new actions since the VAMC’s 2003 order in the 2007 Complaint. 1 Rather, both complaints challenge the same 2003 order, regardless of the different causes of action Irvin ascribes to his claim. As the Supreme Court has held, “[u]nder collateral estoppel, once a court has decided an issue of fact or law necessary to its judgment, that decision may preclude relit-igation of the issue in a suit on a different cause of action involving a party to the first case.” Allen v. McCurry,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
335 F. App'x 821, Counsel Stack Legal Research, https://law.counselstack.com/opinion/frank-irvin-ii-v-united-states-ca11-2009.